Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis. (11th May 2016)

• Record Type: Journal Article
• Authors: Hariman, Richard; Patel, Payal; Strouse, Jennifer; Collins, Michael P.; Rosenthal, Ann
• Other Names: Salazar-Paramo Mario Academic Editor.
• Is Part Of: Case reports in rheumatology. Volume 2016(2016)
• Publication Date: 2016-05-11
• Subjects: Rheumatology -- Periodicals; Rheumatology -- Case studies -- Periodicals; Rheumatic Diseases; Connective Tissue Diseases; Rheumatology; Periodicals; Electronic journals; Case studies; Periodicals; 616.723
• DOI: 10.1155/2016/7906013
• Languages: English
• ISSNs: 2090-6889

Abstract

Abstract : Eosinophilic fasciitis (EF) is a rare disorder involving chronic inflammation of the fascia and connective tissue surrounding muscles, nerves, and blood vessels. While its pathogenesis is not entirely understood, this disorder is thought to be autoimmune or allergic in nature. We present here a case of a 59-year-old male who developed peripheral eosinophilia and subsequent eosinophilic fasciitis during treatment with infliximab. To our knowledge, eosinophilic fasciitis has not been previously described in patients during treatment with an inhibitor of tumor necrosis factor α .